• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

URGO Medical and SteadMed Are Merging Their North American Activities to Become a Leading Player in the Advanced Wound Care Market

Share:

October 1, 2018

French family-owned international healthcare group URGO and US Texas-based company SteadMed announce the merging of their North American medical activities, with Urgo Medical taking a majority stake in this strategic partnership, whose activities will focus on acute and chronic wounds.

The newly formed entity created today, September 26th, takes the name Urgo Medical North America. Its headquarters will remain in Fort Worth, Texas, under the leadership of the former management team.

With a yearly turnover of approximately $20M, Urgo Medical North America will operate in the USA and Canada with ambitions to become a global leading player in the world’s largest advanced wound care market of North America. There is a perfect fit between the range of products of both companies that will enable the new entity to offer best in class treatments to treat acute and chronic wounds.

As a global leader in wound care, URGO Medical is constantly looking for new opportunities to strengthen its international growth. Last year in 2017, 65% of the revenues of URGO Medical were generated abroad, and the company has now a direct presence in more than 20 countries. “Setting foot in the USA represents both a key milestone for our development and a strategic priority. We are happy to enter this new market with our partner SteadMed, who also has a strong expertise in advanced wound care and who will help us to develop innovative solutions to assist healthcare professionals in reducing healing time. Our two companies share the same values: a history of entrepreneurship and the long term vision of a family business,” announces Pierre Moustial, URGO Group CEO.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

SteadMed Medical LLC is a US company based in Fort Worth, Texas, that commercializes advanced wound care products (for optimizing wound bed preparation). The company was created in 2010 by Michael Steadman who is still at the head of the company. SteadMed distributes its range of products Primarily in North America and employs 41 people locally. “This new partnership with URGO is a great opportunity for us to enhance our growth in North America and to launch together new innovative products in advanced wound care, for patients who suffer from wounds associated with diabetes, blood circulation problems, infection and other wound healing complications,” says Michael Steadman, SteadMed Chairman, newly named CEO of URGO Medical North America.

The new entity’s objectives within the next 5 years are to reach $50M in annual turnover while doubling the workforce in Texas and throughout the United States.

URGO Medical North America will dedicate its activities to products that offer relief to patients who suffer from severe wounds, thanks to its portfolio optimized solutions and protocols for healthcare professionals:

– Specifically adapted dressings and treatment protocols for different types of acute and chronic wounds such as Venous leg ulcers, diabetic foot ulcers, pressure ulcers or burns. URGO Medical North America product portfolio will be built upon SteadMed Medical products along with URGO Medical products (the Restore Triact product line). In the near future, these products will be rebranded to Urgo Medical brands.

– Medical trainings to continue improving care and treatment for patients;

– Investment strategy in medical studies to demonstrate the clinical efficiency of treatments to reduce the burden of chronic wounds.

– The company’s digital solution for optimizing the care and treatment pathway, to assist healthcare professionals with diagnosis, customized treatments and care protocols, wound monitoring with alerts relative to the healing trajectory.

Date: October 1, 2018

Source: Cision

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • GE shares surge after Danaher agrees to buy biopharma business for $21.4 billionGE shares surge after Danaher agrees to buy biopharma business for $21.4 billion
  • Livongo unveils Amazon-based voice toolLivongo unveils Amazon-based voice tool
  • LBC Credit Partners Supports the Acquisition of e+CancerCare by Integrated Oncology Network, LLCLBC Credit Partners Supports the Acquisition of e+CancerCare by Integrated Oncology Network, LLC
  • XORTX Announces Closing of US$5 Million Public OfferingXORTX Announces Closing of US$5 Million Public Offering
  • CMS Launches New API to Help Doctors Get Access to Patient RecordsCMS Launches New API to Help Doctors Get Access to Patient Records
  • Proteor to Expand Lower Limb Prosthetics Portfolio Through Its Acquisition of Freedom Innovations AssetsProteor to Expand Lower Limb Prosthetics Portfolio Through Its Acquisition of Freedom Innovations Assets
  • SAS & Duke Health Announce AI Partnership.SAS & Duke Health Announce AI Partnership.
  • UCLA Spin Out DEARhealth Lands $6M for AI-Powered Pathways for Power CareUCLA Spin Out DEARhealth Lands $6M for AI-Powered Pathways for Power Care

Trending This Week

  • Denials Management Named Most Time-Consuming Task in RCM
  • Why Adopting Value-Based Care Models for Autism Care Is Imperative
  • Why AI-Driven Cancer Screening Will Soon Become Standard of Care
  • Bioventus Completes Divestiture of its Wound Business
  • Enzo Biochem Reports Significant Progress Toward Completing the Clinical Lab Asset Sale
  • eMolecules Acquires Specs Compound Handling B.V.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications